Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal bevacizumab for neovascular glaucoma – observational case series
2006-004826-10Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Sep 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevacizumab in neovascular glaucoma (NVG), sponsored by Moorfields Eye Hospital. Primary endpoint: Subjective pain relief. Started Sep 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
neovascular glaucoma (NVG)
Beyond the preview
Go deeper on 2006-004826-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004826-10.